These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10811049)
41. [The testosterone therapy in patients with andropause]. Krysiak R; Okopień B; Gdula-Dymek A Wiad Lek; 2007; 60(7-8):356-64. PubMed ID: 18175556 [TBL] [Abstract][Full Text] [Related]
42. Introduction: defining the role of testosterone in the male. Advani A J Pharm Pract; 2011 Aug; 24(4):365. PubMed ID: 21984772 [No Abstract] [Full Text] [Related]
43. Is there a "male menopause" - and will hormones help? Harv Mens Health Watch; 2001 Jun; 5(11):1-5. PubMed ID: 11439276 [No Abstract] [Full Text] [Related]
44. Growth hormone replacement therapy (GHRT) in children and adolescents: skeletal impact. Mukherjee A; Shalet SM Med Pediatr Oncol; 2003 Sep; 41(3):235-42. PubMed ID: 12868125 [TBL] [Abstract][Full Text] [Related]
45. [Anatomic substratum of therapeutic effects obtained in chorioepithelioma by hormonal treatment (A.C.T.H. plus estrogens, testosterone plus estrogens)]. Badarau L; Gavrilita L; Negura Marderos A Rev Fr Gynecol Obstet; 1968; 63(1):43-51. PubMed ID: 4312490 [No Abstract] [Full Text] [Related]
46. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy. Raynor MC; Carson CC; Pearson MD; Nix JW Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948 [TBL] [Abstract][Full Text] [Related]
48. Replacement therapy in the aging male. Lunenfeld B J Endocrinol Invest; 2002; 25(10 Suppl):2-9. PubMed ID: 12508905 [TBL] [Abstract][Full Text] [Related]
49. The effects of oestrogen on urogenital health. Lachowsky M; Nappi RE Maturitas; 2009 Jun; 63(2):149-51. PubMed ID: 19410391 [TBL] [Abstract][Full Text] [Related]
50. Acne: hormonal concepts and therapy. Thiboutot D Clin Dermatol; 2004; 22(5):419-28. PubMed ID: 15556729 [TBL] [Abstract][Full Text] [Related]
51. DHEA and testosterone in the elderly. Gleicher N; Barad D N Engl J Med; 2007 Feb; 356(6):636-7; author reply 637. PubMed ID: 17290512 [No Abstract] [Full Text] [Related]
52. The aging population--is there a role for endocrine interventions? Nass R; Johannsson G; Christiansen JS; Kopchick JJ; Thorner MO Growth Horm IGF Res; 2009 Apr; 19(2):89-100. PubMed ID: 18977675 [TBL] [Abstract][Full Text] [Related]
53. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead? Miner MM; Seftel AD Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664 [TBL] [Abstract][Full Text] [Related]
54. Should we treat the somatopause? Hoffman AR; Ceda GP J Endocrinol Invest; 1999; 22(10 Suppl):4-6. PubMed ID: 10727025 [No Abstract] [Full Text] [Related]
56. [Hormonal growth retardation and its legitimation. I. Medical indications, treatment and side effects]. Degenhardt A Z Morphol Anthropol; 1984; 75(1):57-76. PubMed ID: 6516530 [No Abstract] [Full Text] [Related]
57. Optimal nutrition, exercise, and hormonal therapy promote muscle anabolism in the elderly. Wolfe RR J Am Coll Surg; 2006 Jan; 202(1):176-80. PubMed ID: 16377511 [No Abstract] [Full Text] [Related]
58. Testosterone replacement therapy for male aging: ASA position statement. J Androl; 2006; 27(2):133-4. PubMed ID: 16474019 [No Abstract] [Full Text] [Related]